Ultrasound quality: experts aim to standardize liver imaging

NCT ID NCT07656181

Recruiting now Knowledge-focused Sponsor: University of Bern Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study gathers international experts to agree on what makes a high-quality contrast-enhanced ultrasound (CEUS) of the liver. Using a Delphi process, they will rate and refine quality indicators. The goal is to create a standardized tool for assessing image quality, improving consistency in diagnosis and research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SonoVue® contrast agent
What this could lead to: If successful, this could lead to standardized quality criteria and a rating tool for liver CEUS exams, helping doctors get clearer and more reliable images.
What could go wrong: This is a small expert consensus study (35 participants), not a clinical trial testing a treatment. The results may not be widely adopted or may need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRAST ENHANCED ULTRASOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTRAST ENHANCED ULTRASOUND LIVER ULTRASONIC DIAGNOSIS

Contacts and locations

Locations

University of Bern
RECRUITING

Bern, Canton of Bern, 3007, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.